VA launches $20M research push to treat veteran brain injuries and prevent suicide
H.R. 6993 — BEACON Act of 2026 · Filed by Jack Bergman (R-MI) · 13 cosponsors · Introduced Jan 9, 2026 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the VA to establish two three-year grant programs totaling $20 million ($10M each) to fund research and treatment trials for chronic mild traumatic brain injury (mTBI) in veterans. The first program awards grants up to $5M per year to nonprofits, academic institutions, and health providers to develop and test neurorehabilitation treatments; the second awards smaller grants ($625K–$1.5M) through an independent third-party administrator to validate treatments and establish standards of care. Both programs prioritize patient-centered, non-pharmacological approaches and require coordination with VA facilities.
Why we flagged it
The bill's core mechanism is a straightforward appropriation and grant program to fund clinical research into TBI treatments for veterans. It is a public health measure, not a tax provision, regulatory change, or commemorative act.
- Section 5 amends VA housing loan fee table, changing June 9, 2034 deadline to July 14, 2034—unrelated to TBI research.
What the text implies
- The bill's requirement that an independent third-party organization administer the second grant program may create a new quasi-governmental entity with significant discretion over research priorities and funding allocation, potentially insulating decisions from direct VA or congressional oversight.
- The emphasis on 'non-pharmacological therapies' and 'patient-centered care' may signal a shift away from pharmaceutical interventions for mTBI, which could affect treatment patterns and pharmaceutical industry interest in this veteran population.
- Mandatory reporting of 'self-harm or suicide-related events' creates a detailed adverse-event database that, while protective, may discourage some providers from participating if they fear liability or reputational risk from reporting negative outcomes.
- The three-year sunset with annual review creates uncertainty for grantees and may limit long-term research continuity; however, the bill permits continued administration of obligations incurred before termination.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Veterans with chronic mild TBI gain access to federally funded research into new neurorehabilitation treatments, with explicit focus on non-pharmacological approaches, mental health outcomes, and suicide risk reduction. The bill mandates rigorous oversight, independent third-party validation, and public reporting of findings, ensuring accountability and transparency in how taxpayer funds are spent on veteran care.
Who stands to gain
- nonprofit organizations with clinical trial capability
- academic institutions conducting TBI research
- non-Department health care providers specializing in neurorehabilitation
- independent research organizations contracted to administer grants
Named in the bill
Department of Veterans Affairs, Veterans Health Administration, nonprofit organizations (501(c)(3)), academic institutions, health care providers, National Center for Posttraumatic Stress Disorder, independent third-party research organization
Where it stands
13 cosponsors: 7 Republicans, 6 Democrats.
- Jan 9, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jan 9, 2026 — Referred to House Committee on Veterans' Affairs · Congress.gov: “Referred to the House Committee on Veterans' Affairs”
- Apr 16, 2026 — Markup held in committee · Congress.gov: “Subcommittee Consideration and Mark-up Session Held”
- May 14, 2026 — Reported out of committee · Congress.gov: “Ordered to be Reported (Amended) by the Yeas and Nays: 13 - 10”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $380,000 in lobbying spend. A filing names 56 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 41% of bills with at least one filing.
Jack Bergman, the sponsor, reported $844,675 in PAC receipts in the 2026 cycle.
- American Psychological Association Services Inc.(fka American Psychological Assn — $340,000 on 1 filing
- Mission Roll Call — $40,000 on 1 filing
Lobbying Disclosure Act filings through Jul 16, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (17,565 characters) on Jul 25, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 16, 2026 · page rendered 2026-10-20.
“VA launches $20M research push to treat veteran brain injuries and prevent suicide” QuorumCivic. https://share.quorumcivic.app/bill/119/hr6993 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.